Ani Pharmaceuticals Inc Cash Flow Statement

Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -46.20M-51.61M-1.57M0.11M28.75M15.38M3.93M-1.08M10.31M-3.04M-35.75M-42.60M-47.90M18.78M-18.52M
Depreciation and Depletion 0.52M0.50M0.60M0.70M0.90M1.20M2.10M4.40M4.80M5.50M7.40M7.50M7.40M
Share-based Compensation 1.25M0.99M1.18M0.04M3.42M3.86M6.07M6.10M6.78M9.22M12.94M10.49M14.60M20.65M29.34M
Deferred Taxes -14.46M-1.88M-8.91M3.56M-5.18M-9.13M-13.21M-16.75M-15.25M-11.74M-21.91M
Cash from Discontinued Operations -0.30M-0.20M
Gains from Sales and Divestitures 0.03M0.03M0.04M0.13M0.12M0.24M
Gains from Investment Securities -0.06M0.07M-0.37M-1.07M0.15M13.26M9.54M0.05M0.07M0.12M1.60M4.71M5.35M
Asset Writedowns and Impairment 0.29M6.68M0.90M0.07M0.45M2.37M0.57M7.60M
Non-cash Items 0.61M16.79M2.22M0.37M0.37M0.61M0.69M
Cash from Operations -18.43M-40.10M-47.87M-0.14M-5.48M22.03M17.26M27.47M39.42M67.07M45.63M15.27M3.32M-31.20M118.96M64.02M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.27M13.60M
Amortization of Deferred Charges 0.22M0.56M6.83M7.28M7.67M8.46M7.02M1.88M2.51M3.96M3.92M0.64M
Depreciation & Amortization (CF) 0.14M0.17M0.15M0.57M1.11M3.88M6.90M22.34M27.93M33.74M44.61M44.64M47.25M59.65M59.79M67.73M
Change in Working Capital
Change in Receivables 0.33M7.08M4.78M4.63M23.96M12.89M4.74M7.29M23.66M5.55M36.91M-3.36M21.09M
Change in Inventory 0.70M0.71M3.47M5.87M1.94M-5.36M0.38M7.66M2.76M-3.22M23.63M5.84M21.29M
Change in Account Payables 0.79M-0.56M0.70M-1.03M6.27M0.00M3.47M5.04M-2.29M10.17M5.04M7.55M0.48M
Change in Accured Expenses -1.55M3.14M0.13M0.20M-0.07M0.24M0.09M0.94M0.64M
Change in Taxes 0.02M4.23M-5.38M3.52M-3.56M6.18M-6.10M4.98M-7.57M-0.16M11.99M-1.42M
Other Working Capital Changes 0.03M0.37M-1.68M0.09M0.19M0.56M0.31M0.65M0.02M1.14M-0.40M1.87M-0.13M0.80M9.02M-2.13M
Investing Activities
Capital Expenditures 0.17M0.06M0.72M0.29M0.19M1.12M2.18M4.57M10.37M5.74M6.63M6.13M2.56M8.88M8.87M16.24M
Sales of Property, Plant and Equipment 0.00M2.65M0.75M13.51M
Change in Intangibles 34.63M30.50M144.49M97.62M5.17M20.91M62.19M21.08M7.58M9.64M0.72M
Acquisitions 24.75M18.20M16.47M84.49M0.03M401.28M
Change in Acquisitions & Divestments 3.03M
Cash from Investing Activities 2.86M-0.06M-0.72M-0.29M20.27M-35.75M-32.68M-149.06M-107.99M-27.38M-27.55M-68.32M-105.48M-15.74M-18.51M-404.72M
Financing Activities
Other financing activities -2.43M0.26M0.78M0.36M0.62M0.35M2.98M5.74M0.62M13.97M17.35M
Cash from Financing Activities 33.67M48.45M67.66M0.44M-3.69M171.65M1.07M-0.73M72.36M-27.82M1.25M-1.44M194.59M-5.13M67.44M264.94M
Dividend Payments
Dividends Paid - Common 0.19M1.62M1.62M1.62M
Additional items
Exchange Rate Effect -0.47M
Change in Cash 18.10M8.30M19.07M0.74M11.09M157.93M-14.35M-122.32M3.78M11.88M19.33M-54.49M92.43M-52.07M167.89M-76.23M
Beginning Cash Balance 11.76M29.86M-19.07M-0.73M0.01M11.11M169.04M149.68M27.36M31.13M43.00M62.36M7.87M100.30M53.23M221.09M
Free Cash Flow -18.60M-40.16M-48.59M-0.43M-5.67M20.91M15.08M22.91M29.05M61.33M39.00M9.13M0.77M-40.08M110.09M47.78M
Net Cash Flow 18.10M8.30M19.07M0.01M11.09M157.93M-14.35M-122.32M3.78M11.88M19.33M-54.49M92.43M-52.07M167.89M-75.76M